valine has been researched along with Hypertension, Renal in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bader, M; Baltatu, OC; Campos, LA; Louie, P; Schumacher, C; Zaugg, CE | 1 |
| Deák, L; Farsang, C; Haller, H; Handrock, R; Klebs, S; Meier, M; Menne, J; Sieder, C | 1 |
| Faedda, R; Loriga, G; Ruggenenti, P; Sanna, M; Satta, AE; Vidili, G | 1 |
| Rosa, EM; Viecceli, C | 1 |
| Ecder, T; Kashihara, N; Locatelli, F; Palmer, BF | 1 |
| Al-Abadi, E; Milford, DV; Smith, M | 1 |
| Abe, M; Baba, S; Maruyama, N; Okada, K; Soma, M; Suzuki, H; Takashima, H; Yoshida, Y | 1 |
| Goto, SN; Mizuno, Y; Takagi, H; Umemoto, T; Yamamoto, H | 1 |
| Eberhardt, W; Fierlbeck, W; Gauer, S; Geiger, H; Hartner, A; Hauser, IA | 1 |
| Chijiwa, T; Hashimoto, K; Horino, T; Hosokawa, T; Ito, H; Sasaoka, A; Tanimoto, N; Yoshida, T | 1 |
| Abadir, P; Awad, A; Siragy, HM; Webb, R | 1 |
| He, SX; Ling, HX; Sun, SY | 1 |
| Chowdhury, NA; Cooper, SA; Ferrario, C; Gallagher, PE; Habibi, J; Hayden, MR; Link, CD; Sowers, JR; Stump, CS; Tallant, EA; Whaley-Connell, AT; Wiedmeyer, CE | 1 |
| Aslam, S; Leone, A; Santha, T; Wilcox, C | 1 |
| Allegrini, P; Baum, HP; Cumin, F; de Gasparo, M; Drexler, H; Kästner, S; Laurent, D; Studer, R; Whitebread, S; Zierhut, W | 1 |
| Hayashi, N; Inukai, T; Kometani, M; Nakao, K; Yamamoto, S | 1 |
| Bünten, B; Grabensee, B; Németh, R; Plum, J | 1 |
| Ganten, D; Geiger, H; Hartner, A; Hilgers, KF; Hugo, C; Mai, M; Mann, JF; Porst, M; Veelken, R; Wittmann, M | 1 |
2 review(s) available for valine and Hypertension, Renal
| Article | Year |
|---|---|
Renal protective effect of RAAS blockade across the renal continuum, with a review of the efficacy and safety of valsartan.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cytoprotection; Humans; Hypertension; Hypertension, Renal; Kidney; Kidney Failure, Chronic; Models, Biological; Renin-Angiotensin System; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2009 |
Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Hypertension, Renal; Imidazoles; Interleukin-6; Obesity; Prospective Studies; Publication Bias; Randomized Controlled Trials as Topic; Stents; Telmisartan; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2013 |
6 trial(s) available for valine and Hypertension, Renal
| Article | Year |
|---|---|
Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial.
Topics: Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Lisinopril; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
Renal hemodynamics and renoprotection.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Female; Humans; Hypertension, Renal; Male; Middle Aged; Proteinuria; Renal Circulation; Renin; Renin-Angiotensin System; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
Aliskiren reduces home blood pressure and albuminuria in patients with hypertensive nephrosclerosis.
Topics: Adult; Aged; Albuminuria; Amides; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Female; Fumarates; Humans; Hypertension; Hypertension, Renal; Male; Middle Aged; Nephritis; Nephrosclerosis; Tetrazoles; Valine; Valsartan | 2013 |
[Clinical observation of the therapeutic effect of valsartan for renal hypertension in 64 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Creatinine; Electrolytes; Humans; Hypertension, Renal; Middle Aged; Proteinuria; Tetrazoles; Valine; Valsartan | 2003 |
Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Arginine; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Methylation; Middle Aged; Oxidative Stress; Renal Dialysis; Tetrazoles; Valine; Valsartan | 2006 |
Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension.
Topics: Aged; Albuminuria; Angiotensin II; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Creatinine; Dextrans; Double-Blind Method; Erythrocyte Count; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Inulin; Kidney Failure, Chronic; Kidney Glomerulus; Male; Middle Aged; Molecular Weight; p-Aminohippuric Acid; Particle Size; Potassium; Prospective Studies; Proteinuria; Renal Circulation; Tetrazoles; Valine; Valsartan | 1998 |
11 other study(ies) available for valine and Hypertension, Renal
| Article | Year |
|---|---|
Avosentan is protective in hypertensive nephropathy at doses not causing fluid retention.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Antihypertensive Agents; Diuresis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hematocrit; Humans; Hypertension, Renal; Kidney; Male; Nephritis; Pyridines; Pyrimidines; Rats; Rats, Transgenic; Renin; Tetrazoles; Valine; Valsartan | 2014 |
Interesting findings in the VALERIA trial.
Topics: Albuminuria; Antihypertensive Agents; Drug Therapy, Combination; Humans; Hypertension, Renal; Lisinopril; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan | 2009 |
A patient with bilateral facial palsy associated with hypertension and chickenpox: learning points.
Topics: Acyclovir; Antihypertensive Agents; Antiviral Agents; Chickenpox; Child; Cooperative Behavior; Diagnosis, Differential; Facial Paralysis; Follow-Up Studies; Headache; Humans; Hypertension, Renal; Interdisciplinary Communication; Losartan; Male; Neurologic Examination; Valacyclovir; Valine | 2010 |
Differential regulation of osteopontin expression in the clipped and nonclipped kidney of two-kidney, one-clip hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Gene Expression; Hypertension, Renal; Kidney; Male; Monocytes; Osteopontin; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; RNA, Messenger; Sialoglycoproteins; Surgical Instruments; Tetrazoles; Valine; Valsartan | 2003 |
[Successful treatment of combination therapy using an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker in a patient with IgA nephropathy].
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Hypertension, Renal; Renin-Angiotensin System; Tetrazoles; Thiazepines; Treatment Outcome; Valine; Valsartan | 2003 |
The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats.
Topics: Albuminuria; Animals; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Space; Hypertension, Renal; Kidney; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2003 |
Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Animals, Genetically Modified; Blood Pressure; Disease Models, Animal; Hypertension, Renal; Kidney Glomerulus; Male; Malondialdehyde; Mice; Microscopy, Electron, Transmission; NADPH Oxidases; Neprilysin; Oxidative Stress; Peptidyl-Dipeptidase A; Podocytes; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2006 |
[Valsartan: arguments for the high dose concept].
Topics: Angiotensin II Type 1 Receptor Blockers; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Humans; Hypertension, Renal; Proteinuria; Tetrazoles; Valine; Valsartan | 2006 |
Left ventricular wall stress and sarcoplasmic reticulum Ca(2+)-ATPase gene expression in renal hypertensive rats: dose-dependent effects of ACE inhibition and AT1-receptor blockade.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Benzazepines; Blotting, Northern; Calcium-Transporting ATPases; Dose-Response Relationship, Drug; Heart Ventricles; Hypertension, Renal; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Rats; Rats, Inbred WKY; Sarcoplasmic Reticulum; Tetrazoles; Valine; Valsartan | 1996 |
Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Dogs; Enalapril; Heart Rate; Hypertension; Hypertension, Renal; Male; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Tetrazoles; Valine; Valsartan | 1997 |
Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Chemokine CCL2; Chemotaxis, Leukocyte; Gene Expression; Hypertension, Renal; Kidney; Kidney Failure, Chronic; Macrophages; Monocytes; Nephrosclerosis; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Mutant Strains; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2000 |